Clinical Trial Update: Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy study of ceftaroline for Staphylococcus aureus bacteremia and MRSA bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Bacteremia
• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Teflaro (ceftaroline fosamil)

Snippet

Sponsor: Forest Laboratories | Conditions: Staphylococcus Aureus Bacteremia, Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia | Phase 4 | Status: COMPLETED